{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:31:25Z","timestamp":1788449485993,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017668","name":"Key Research and Development Program of Anhui Province","doi-asserted-by":"crossref","award":["No. 202104j0702"],"award-info":[{"award-number":["No. 202104j0702"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68755-3","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T03:46:34Z","timestamp":1722570394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns"],"prefix":"10.1038","volume":"14","author":[{"given":"Yu","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexue","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingtao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"68755_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/1078-0432.CCR-19-2169","volume":"26","author":"K Sweet","year":"2020","unstructured":"Sweet, K. et al. Phase I clinical trial of selinexor in combination with daunorubicin and cytarabine in previously untreated poor-risk acute myeloid leukemia. Clin. Cancer Res. 26, 54\u201360. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2169 (2020).","journal-title":"Clin. Cancer Res."},{"key":"68755_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","volume":"10","author":"NJ Short","year":"2020","unstructured":"Short, N. J. et al. Advances in the treatment of acute myeloid leukemia: New drugs and new challenges. Cancer Discov. 10, 506\u2013525. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1011 (2020).","journal-title":"Cancer Discov."},{"key":"68755_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/bjh.17746","volume":"196","author":"S Kayser","year":"2022","unstructured":"Kayser, S. & Levis, M. J. Updates on targeted therapies for acute myeloid leukaemia. Br. J. Haematol. 196, 316\u2013328. https:\/\/doi.org\/10.1111\/bjh.17746 (2022).","journal-title":"Br. J. Haematol."},{"key":"68755_CR4","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood-2016-11-750158","volume":"129","author":"R Garzon","year":"2017","unstructured":"Garzon, R. et al. A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia. Blood 129, 3165\u20133174. https:\/\/doi.org\/10.1182\/blood-2016-11-750158 (2017).","journal-title":"Blood"},{"key":"68755_CR5","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","volume":"107","author":"FR Appelbaum","year":"2006","unstructured":"Appelbaum, F. R. et al. Age and acute myeloid leukemia. Blood 107, 3481\u20133485. https:\/\/doi.org\/10.1182\/blood-2005-09-3724 (2006).","journal-title":"Blood"},{"key":"68755_CR6","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1158\/1078-0432.CCR-17-1556","volume":"24","author":"X Jiang","year":"2018","unstructured":"Jiang, X. et al. Disruption of Wnt\/\u03b2-catenin exerts antileukemia activity and synergizes with FLT3 inhibition in FLT3-mutant acute myeloid leukemia. Clin. Cancer Res. 24, 2417\u20132429. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1556 (2018).","journal-title":"Clin. Cancer Res."},{"key":"68755_CR7","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. 374, 2209\u20132221. https:\/\/doi.org\/10.1056\/NEJMoa1516192 (2016).","journal-title":"N. Engl. J. Med."},{"key":"68755_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/cdd.2015.136","volume":"23","author":"N Lalaoui","year":"2016","unstructured":"Lalaoui, N., Johnstone, R. & Ekert, P. G. Autophagy and AML\u2014food for thought. Cell Death Differ. 23, 5\u20136. https:\/\/doi.org\/10.1038\/cdd.2015.136 (2016).","journal-title":"Cell Death Differ."},{"key":"68755_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.gendis.2023.03.010","volume":"11","author":"D Hu","year":"2024","unstructured":"Hu, D. et al. Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma. Genes Dis. 11, 516\u2013519. https:\/\/doi.org\/10.1016\/j.gendis.2023.03.010 (2024).","journal-title":"Genes Dis."},{"key":"68755_CR10","doi-asserted-by":"publisher","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int. J. Surg. (London, England) 107, 106936. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106936 (2022).","journal-title":"Int. J. Surg. (London, England)"},{"key":"68755_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/15548627.2016.1245263","volume":"13","author":"S Piya","year":"2017","unstructured":"Piya, S., Andreeff, M. & Borthakur, G. Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia. Autophagy 13, 214\u2013215. https:\/\/doi.org\/10.1080\/15548627.2016.1245263 (2017).","journal-title":"Autophagy"},{"key":"68755_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00992","author":"B Lu","year":"2018","unstructured":"Lu, B. et al. The Role of ferroptosis in cancer development and treatment response. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00992 (2018).","journal-title":"Front. Pharmacol."},{"key":"68755_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12859-023-05148-9","volume":"24","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y., He, J., Li, Z. & Yang, W. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia. BMC Bioinform. 24, 37. https:\/\/doi.org\/10.1186\/s12859-023-05148-9 (2023).","journal-title":"BMC Bioinform."},{"key":"68755_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2022.2101337","author":"D Hu","year":"2022","unstructured":"Hu, D. et al. Multimolecular characteristics of cell-death related hub genes in human cancers: A comprehensive pan-cancer analysis. Cell Cycle (Georgetown, Tex.) https:\/\/doi.org\/10.1080\/15384101.2022.2101337 (2022).","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"68755_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nri3743","volume":"14","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A., Stockwell, B. R., Krautwald, S. & Anders, H. J. Regulated cell death and inflammation: An auto-amplification loop causes organ failure. Nat. Rev. Immunol. 14, 759\u2013767. https:\/\/doi.org\/10.1038\/nri3743 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"68755_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell Biol. 25, 404\u2013414. https:\/\/doi.org\/10.1038\/s41556-023-01091-2 (2023).","journal-title":"Nat. Cell Biol."},{"key":"68755_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P. & Kroemer, G. The molecular machinery of regulated cell death. Cell Res. 29, 347\u2013364. https:\/\/doi.org\/10.1038\/s41422-019-0164-5 (2019).","journal-title":"Cell Res."},{"key":"68755_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2017.03.001","volume":"31","author":"S Mohr","year":"2017","unstructured":"Mohr, S. et al. Hoxa9 and Meis1 cooperatively induce addiction to Syk signaling by suppressing miR-146a in acute myeloid leukemia. Cancer Cell 31, 549-562.e511. https:\/\/doi.org\/10.1016\/j.ccell.2017.03.001 (2017).","journal-title":"Cancer Cell"},{"key":"68755_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood-2018-08-869503","volume":"133","author":"M Sarraf Yazdy","year":"2019","unstructured":"Sarraf Yazdy, M., Mato, A. R. & Cheson, B. D. Combinations or sequences of targeted agents in CLL: Is the whole greater than the sum of its parts (Aristotle, 360 BC)?. Blood 133, 121\u2013129. https:\/\/doi.org\/10.1182\/blood-2018-08-869503 (2019).","journal-title":"Blood"},{"key":"68755_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine, B. & Kroemer, G. Biological functions of autophagy genes: A disease perspective. Cell 176, 11\u201342. https:\/\/doi.org\/10.1016\/j.cell.2018.09.048 (2019).","journal-title":"Cell"},{"key":"68755_CR21","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1038\/s41375-022-01678-y","volume":"36","author":"SE Koschade","year":"2022","unstructured":"Koschade, S. E. et al. Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia. Leukemia 36, 2396\u20132407. https:\/\/doi.org\/10.1038\/s41375-022-01678-y (2022).","journal-title":"Leukemia"},{"key":"68755_CR22","doi-asserted-by":"publisher","first-page":"111652","DOI":"10.1016\/j.biopha.2021.111652","volume":"142","author":"C Cheng","year":"2021","unstructured":"Cheng, C. et al. Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C. Biomed. Pharmacother. Biomed. Pharmacother. 142, 111652. https:\/\/doi.org\/10.1016\/j.biopha.2021.111652 (2021).","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"68755_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/genes13101837","author":"Y Sun","year":"2022","unstructured":"Sun, Y., Wang, R., Xie, S., Wang, Y. & Liu, H. A novel identified necroptosis-related risk signature for prognosis prediction and immune infiltration indication in acute myeloid leukemia patients. Genes https:\/\/doi.org\/10.3390\/genes13101837 (2022).","journal-title":"Genes"},{"key":"68755_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526\u2013531. https:\/\/doi.org\/10.1038\/s41586-018-0623-z (2018).","journal-title":"Nature"},{"key":"68755_CR25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1182\/blood-2013-12-540716","volume":"124","author":"T Herold","year":"2014","unstructured":"Herold, T. et al. Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis. Blood 124, 1304\u20131311. https:\/\/doi.org\/10.1182\/blood-2013-12-540716 (2014).","journal-title":"Blood"},{"key":"68755_CR26","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41467-023-36969-0","volume":"14","author":"MM Naldini","year":"2023","unstructured":"Naldini, M. M. et al. Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia. Nat. Commun. 14, 1285. https:\/\/doi.org\/10.1038\/s41467-023-36969-0 (2023).","journal-title":"Nat. Commun."},{"key":"68755_CR27","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat. Commun. 13, 816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6 (2022).","journal-title":"Nat. Commun."},{"key":"68755_CR28","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking. Bioinformatics (Oxford, England) 26, 1572\u20131573. https:\/\/doi.org\/10.1093\/bioinformatics\/btq170 (2010).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"68755_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. https:\/\/doi.org\/10.1126\/scisignal.2004088 (2013).","journal-title":"Sci. Signal."},{"key":"68755_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7. https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinform."},{"key":"68755_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun. (London, England) 40, 301\u2013312. https:\/\/doi.org\/10.1002\/cac2.12067 (2020).","journal-title":"Cancer Commun. (London, England)"},{"key":"68755_CR32","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin-Gadda, H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32, 5381\u20135397. https:\/\/doi.org\/10.1002\/sim.5958 (2013).","journal-title":"Stat. Med."},{"key":"68755_CR33","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba, A. C. et al. Discrimination and calibration of clinical prediction models: Users\u2019 guides to the medical literature. JAMA 318, 1377\u20131384. https:\/\/doi.org\/10.1001\/jama.2017.12126 (2017).","journal-title":"JAMA"},{"key":"68755_CR34","unstructured":"Zhang, J. ClusterGVis: One-step to Cluster and Visualize Gene Expression Matrix. (2022)"},{"issue":"6282","key":"68755_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I., Izar, B. & Prakadan, S. M. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352(6282), 189\u2013196. https:\/\/doi.org\/10.1126\/science.aad0501 (2016).","journal-title":"Science"},{"key":"68755_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati, G. S. et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science 367, 405\u2013411. https:\/\/doi.org\/10.1126\/science.aax0249 (2020).","journal-title":"Science"},{"key":"68755_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386. https:\/\/doi.org\/10.1038\/nbt.2859 (2014).","journal-title":"Nat. Biotechnol."},{"key":"68755_CR38","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng, D. et al. IOBR: Multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front. Immunol. 12, 687975. https:\/\/doi.org\/10.3389\/fimmu.2021.687975 (2021).","journal-title":"Front. Immunol."},{"key":"68755_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu, J. et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12, 21. https:\/\/doi.org\/10.1186\/s13073-020-0721-z (2020).","journal-title":"Genome Med."},{"key":"68755_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab260 (2021).","journal-title":"Brief. Bioinform."},{"key":"68755_CR41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41419-020-02904-0","volume":"11","author":"X Sun","year":"2020","unstructured":"Sun, X. et al. Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib. Cell Death Dis. 11, 702. https:\/\/doi.org\/10.1038\/s41419-020-02904-0 (2020).","journal-title":"Cell Death Dis."},{"key":"68755_CR42","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1128\/mcb.25.14.5834-5845.2005","volume":"25","author":"A Sofer","year":"2005","unstructured":"Sofer, A., Lei, K., Johannessen, C. M. & Ellisen, L. W. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol. Cell. Biol. 25, 5834\u20135845. https:\/\/doi.org\/10.1128\/mcb.25.14.5834-5845.2005 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"68755_CR43","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/jcmm.14831","volume":"24","author":"Z Cheng","year":"2020","unstructured":"Cheng, Z. et al. Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia. J. Cell. Mol. Med. 24, 1067\u20131075. https:\/\/doi.org\/10.1111\/jcmm.14831 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"68755_CR44","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1093\/nar\/gkx039","volume":"45","author":"JP Plotnik","year":"2017","unstructured":"Plotnik, J. P. & Hollenhorst, P. C. Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2. Nucleic Acids Res. 45, 4452\u20134462. https:\/\/doi.org\/10.1093\/nar\/gkx039 (2017).","journal-title":"Nucleic Acids Res."},{"key":"68755_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.neo.2016.07.006","volume":"18","author":"JR Pitarresi","year":"2016","unstructured":"Pitarresi, J. R. et al. Stromal ETS2 regulates chemokine production and immune cell recruitment during acinar-to-ductal metaplasia. Neoplasia (New York, N.Y.) 18, 541\u2013552. https:\/\/doi.org\/10.1016\/j.neo.2016.07.006 (2016).","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"68755_CR46","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.4049\/jimmunol.169.9.4873","volume":"169","author":"A Zaldumbide","year":"2002","unstructured":"Zaldumbide, A., Carlotti, F., Pognonec, P. & Boulukos, K. E. The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes. J. Immunol. 169, 4873\u20134881. https:\/\/doi.org\/10.4049\/jimmunol.169.9.4873 (2002).","journal-title":"J. Immunol."},{"key":"68755_CR47","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ejcb.2014.06.003","volume":"93","author":"G Gadea","year":"2014","unstructured":"Gadea, G. & Blangy, A. Dock-family exchange factors in cell migration and disease. Eur. J. Cell Biol. 93, 466\u2013477. https:\/\/doi.org\/10.1016\/j.ejcb.2014.06.003 (2014).","journal-title":"Eur. J. Cell Biol."},{"key":"68755_CR48","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41375-022-01632-y","volume":"36","author":"AE Meyer","year":"2022","unstructured":"Meyer, A. E. et al. Combinatorial genetics reveals the Dock1-Rac2 axis as a potential target for the treatment of NPM1; Cohesin mutated AML. Leukemia 36, 2032\u20132041. https:\/\/doi.org\/10.1038\/s41375-022-01632-y (2022).","journal-title":"Leukemia"},{"key":"68755_CR49","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1182\/blood.V116.21.1042.1042","volume":"116","author":"A Kentsis","year":"2010","unstructured":"Kentsis, A. et al. Aberrant expression of hepatocyte growth factor induces autocrine MET activation providing a novel therapeutic target in acute myeloid leukemia. Blood 116, 1042. https:\/\/doi.org\/10.1182\/blood.V116.21.1042.1042 (2010).","journal-title":"Blood"},{"key":"68755_CR50","doi-asserted-by":"publisher","first-page":"608932","DOI":"10.3389\/fonc.2021.608932","volume":"11","author":"C Yin","year":"2021","unstructured":"Yin, C. et al. High expression of CLEC11A predicts favorable prognosis in acute myeloid leukemia. Front. Oncol. 11, 608932. https:\/\/doi.org\/10.3389\/fonc.2021.608932 (2021).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68755-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68755-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68755-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T03:49:11Z","timestamp":1722570551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68755-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68755"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68755-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17874"}}